Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Braz J Microbiol ; 55(3): 2119-2130, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38954220

RESUMEN

Biosurfactants, sustainable alternatives to petrochemical surfactants, are gaining attention for their potential in medical applications. This study focuses on producing, purifying, and characterizing a glycolipid biosurfactant from Candida sp. UFSJ7A, particularly for its application in biofilm prevention on siliconized latex catheter surfaces. The glycolipid was extracted and characterized, revealing a critical micellar concentration (CMC) of 0.98 mg/mL, indicating its efficiency at low concentrations. Its composition, confirmed through Fourier transform infrared spectroscopy (FT-IR) and thin layer chromatography (TLC), identified it as an anionic biosurfactant with a significant ionic charge of -14.8 mV. This anionic nature contributes to its biofilm prevention capabilities. The glycolipid showed a high emulsification index (E24) for toluene, gasoline, and soy oil and maintained stability under various pH and temperature conditions. Notably, its anti-adhesion activity against biofilms formed by Escherichia coli, Enterococcus faecalis, and Candida albicans was substantial. When siliconized latex catheter surfaces were preconditioned with 2 mg/mL of the glycolipid, biofilm formation was reduced by up to 97% for E. coli and C. albicans and 57% for E. faecalis. These results are particularly significant when compared to the efficacy of conventional surfactants like SDS, especially for E. coli and C. albicans. This study highlights glycolipids' potential as a biotechnological tool in reducing biofilm-associated infections on medical devices, demonstrating their promising applicability in healthcare settings.


Asunto(s)
Biopelículas , Candida , Catéteres , Glucolípidos , Tensoactivos , Glucolípidos/farmacología , Glucolípidos/química , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Tensoactivos/farmacología , Tensoactivos/química , Candida/efectos de los fármacos , Candida/fisiología , Catéteres/microbiología , Látex/química , Látex/farmacología , Escherichia coli/efectos de los fármacos , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/fisiología , Candida albicans/efectos de los fármacos , Candida albicans/fisiología
2.
Biol Trace Elem Res ; 201(6): 2963-2981, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35994139

RESUMEN

New bone cement type that combines Sr2 + /Mg2 + or Sr2 + /Zn2 + co-substituted nano-hydroxyapatite (n-HAs) with calcium phosphate dibasic and chitosan/gelatin polymers was developed to increase adhesion and cellular response. The cements were physicochemically described and tested in vitro using cell cultures. All cements exhibited quite hydrophilic and had high washout resistance. Cement releases Ca2 + , Mg2 + , Sr2 + , and Zn2 + in concentrations that are suitable for osteoblast proliferation and development. All of the cements stimulated cell proliferation in fibroblasts, endothelial cells, and osteoblasts, were non-cytotoxic, and produced apatite. Cements containing co-substituted n-HAs had excellent cytocompatibility, which improved osteoblast adhesion and cell proliferation. These cements had osteoinductive potential, stimulating extracellular matrix (ECM) mineralization and differentiation of MC3T3-E1 cells by increasing ALP and NO production. The ions Ca2 + , Mg2 + , Zn2 + , and Sr2 + appear to cooperate in promoting osteoblast function. The C3 cement (HA-SrMg5%), which was made up of n-HA co-substituted with 5 mol% Sr and 5 mol% Mg, showed exceptional osteoinductive capacity in terms of bone regeneration, indicating that this new bone cement could be a promising material for bone replacement.


Asunto(s)
Cementos para Huesos , Durapatita , Durapatita/farmacología , Cementos para Huesos/metabolismo , Zinc/farmacología , Zinc/metabolismo , Magnesio/farmacología , Magnesio/metabolismo , Estroncio/farmacología , Células Endoteliales/metabolismo , Fosfatos de Calcio/metabolismo , Osteoblastos/metabolismo , Regeneración Ósea
3.
Carbohydr Polym ; 201: 218-227, 2018 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-30241814

RESUMEN

This study describes the chemical modification of chitosan to produce a novel bifunctionalized adsorbent material (C4) for the removal of Cu2+ and oxyanions of Cr6+ from a single aqueous solution. The chemical modifications allowed C4 to be insoluble under acidic conditions, improving the chemical properties of the modified chitosan in aqueous solution. C4 adsorbent was synthesized by reaction of the amino group of chitosan with 2-pyridinecarboxaldehyde, a reduction of imine group, followed by esterification with EDTA dianhydride (EDTAD). C4 was characterized by solid-state 13C nuclear magnetic resonance, infrared spectroscopy, and elemental analysis. The adsorption studies of Cu2+ and oxyanions of Cr6+ in a batch mode were evaluated as a function of the contact time (kinetics), solution pH, and initial metal ion concentration. The maximum adsorption capacities (Qmax) of C4 for the adsorption of Cu2+ (pH 5.5) and Cr6+ (pH 2.0) were 2.60 and 3.50 mmol/g, respectively. The reusability of the recovered C4 adsorbent was also evaluated.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA